On Wednesday, Cibus Inc (NASDAQ:CBUS) announced that it has expanded its intellectual property coverage for ten gene editing and trait families.

Over the last six months, intellectual property expansion has covered several areas, including gene editing, productivity traits, and quality traits, like high-fiber wheat.

This strengthens the company's patent coverage in geographies including, but not limited to, Europe, Asia, Latin America, Canada, and the U.S.

Cibus is focused on developing complex gene-edited traits in plants, such as Pod Shatter Reduction in Canola and Herbicide Tolerance in Rice.

The company's plant trait intellectual property is developed using its Rapid Trait Development System (RTDS), which includes Gene Repair Oligonucleotides (GRON) and Transcription activator-like effector nuclease (TALEN) technology.

The patents announced solidify Cibus' intellectual property depth, driving product development and highlighting the strengths of its diversified portfolio of traits.

Between Cibus and legacy Calyxt, Cibus now has rights to over 1,000 patents and patents applied for, including core original gene editing patents in agriculture.

"We are pleased with the recognition of the patent offices in many countries, who through their decisions have validated our know-how and ability to develop gene-edited traits," commented Greg Gocal, Co-Founder, Executive Vice President and Chief Scientific Officer at Cibus.

Noel Sauer, Senior Vice President of Research at Cibus, added, "Cibus' technology team actively supports the company's commercial advancement efforts through protection of our trait and gene editing intellectual property. Importantly, protected traits can help accelerate our seed company customers' timelines to farmer's fields across global markets."

Price Action: CBUS shares closed at $9.00 on Tuesday.